Significance of microvascular density (MVD) in cervical cancer recurrence

. The purpose of this retrospective study of 118 patients with squamous cell cervical cancer from January 1990 to December 1993 was to evaluate angiogenesis as predictive factor of recurrence in cervical cancer stages II–III treated with standard radiotherapy. Microvessel density (MVD) was evaluated...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of gynecological cancer 2003-11, Vol.13 (6), p.856-862
Hauptverfasser: Cantu De León, D., Lopez‐Graniel, C., Frias Mendivil, M., Chanona Vilchis, G., Gomez, C., De La Garza Salazar, J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 862
container_issue 6
container_start_page 856
container_title International journal of gynecological cancer
container_volume 13
creator Cantu De León, D.
Lopez‐Graniel, C.
Frias Mendivil, M.
Chanona Vilchis, G.
Gomez, C.
De La Garza Salazar, J.
description . The purpose of this retrospective study of 118 patients with squamous cell cervical cancer from January 1990 to December 1993 was to evaluate angiogenesis as predictive factor of recurrence in cervical cancer stages II–III treated with standard radiotherapy. Microvessel density (MVD) was evaluated and correlated with other prognostic factors. MVD was greater than 20 in 67.8% of patients with recurrence (P = 0.002) in comparison to 39% of patients without. Disease‐free survival was shorter in stage IIA and MVD >20 (P = 0.0193) as well as for stage IIB (P 20 (P = 0.0316). For stage IIA and MVD >20 survival was shorter (P = 0.0008) for stage IIB (P 20 had poorer disease‐free interval and survival (P = 0.0029). MVD in patients with squamous cell cervical cancer stage II and age younger than 40 may play a role in predicting recurrence and survival.
doi_str_mv 10.1111/j.1525-1438.2003.13399.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71500197</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71500197</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4778-a2d074120f5a5593a225ec9b59afa88f00f47c24996caa2bc838ae468c2401fd3</originalsourceid><addsrcrecordid>eNqNkF9PHCEUxYmpUWv9CoYn0z7MyN8FXpo0trXbaHyoNn0jLHupbNkZhR11v32Z3Y19LQnhAOfcCz-EMCUtreN80VLJZEMF1y0jhLeUc2Palz109HrxpmoidKMN_XWI3payIIQYRswBOqRioiRn4ghNf8TfXQzRu84D7gNeRp_7J1f8kFzGc-hKXK3x--ufnz_g2GEP-amaE94EMs7gh5yh6ndoP7hU4GS3HqO7r19uL741VzeX04tPV40XSunGsTlRgjISpJPScMeYBG9m0rjgtA6EBKE8E8ZMvHNs5jXXDsRE1zNCw5wfo7Nt3YfcPw5QVnYZi4eUXAf9UKyikhBqVDXqrbF-qJQMwT7kuHR5bSmxI0a7sCMtO9KyI0a7wWhfavR012OYLWH-L7jjVg1ia3ju0wpy-ZOGZ8j2Hlxa3VsykpZKNWNRSuuuqZPqGvu4i8UE6_9-j51-v9xI_hfZv5Aj</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71500197</pqid></control><display><type>article</type><title>Significance of microvascular density (MVD) in cervical cancer recurrence</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Cantu De León, D. ; Lopez‐Graniel, C. ; Frias Mendivil, M. ; Chanona Vilchis, G. ; Gomez, C. ; De La Garza Salazar, J.</creator><creatorcontrib>Cantu De León, D. ; Lopez‐Graniel, C. ; Frias Mendivil, M. ; Chanona Vilchis, G. ; Gomez, C. ; De La Garza Salazar, J.</creatorcontrib><description>. The purpose of this retrospective study of 118 patients with squamous cell cervical cancer from January 1990 to December 1993 was to evaluate angiogenesis as predictive factor of recurrence in cervical cancer stages II–III treated with standard radiotherapy. Microvessel density (MVD) was evaluated and correlated with other prognostic factors. MVD was greater than 20 in 67.8% of patients with recurrence (P = 0.002) in comparison to 39% of patients without. Disease‐free survival was shorter in stage IIA and MVD &gt;20 (P = 0.0193) as well as for stage IIB (P &lt; 0.05 ), but not for IIIB (P = 0.1613 ). Global survival was significantly shorter when MVD was &gt;20 (P = 0.0316). For stage IIA and MVD &gt;20 survival was shorter (P = 0.0008) for stage IIB (P &lt; 0.05) but not for IIIB (P = 0.14) . Patients younger than 40 years and MVD &gt;20 had poorer disease‐free interval and survival (P = 0.0029). MVD in patients with squamous cell cervical cancer stage II and age younger than 40 may play a role in predicting recurrence and survival.</description><identifier>ISSN: 1048-891X</identifier><identifier>EISSN: 1525-1438</identifier><identifier>DOI: 10.1111/j.1525-1438.2003.13399.x</identifier><identifier>PMID: 14675324</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Inc</publisher><subject>Adult ; Age Factors ; Aged ; angiogenesis ; Carcinoma, Squamous Cell - blood supply ; Carcinoma, Squamous Cell - pathology ; Carcinoma, Squamous Cell - radiotherapy ; cervical cancer ; Disease-Free Survival ; Female ; Humans ; locally advanced ; Microcirculation ; Middle Aged ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Neovascularization, Pathologic ; Retrospective Studies ; Risk Factors ; Uterine Cervical Neoplasms - blood supply ; Uterine Cervical Neoplasms - pathology ; Uterine Cervical Neoplasms - radiotherapy</subject><ispartof>International journal of gynecological cancer, 2003-11, Vol.13 (6), p.856-862</ispartof><rights>2003 Blackwell Science Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4778-a2d074120f5a5593a225ec9b59afa88f00f47c24996caa2bc838ae468c2401fd3</citedby><cites>FETCH-LOGICAL-c4778-a2d074120f5a5593a225ec9b59afa88f00f47c24996caa2bc838ae468c2401fd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1525-1438.2003.13399.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1525-1438.2003.13399.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14675324$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cantu De León, D.</creatorcontrib><creatorcontrib>Lopez‐Graniel, C.</creatorcontrib><creatorcontrib>Frias Mendivil, M.</creatorcontrib><creatorcontrib>Chanona Vilchis, G.</creatorcontrib><creatorcontrib>Gomez, C.</creatorcontrib><creatorcontrib>De La Garza Salazar, J.</creatorcontrib><title>Significance of microvascular density (MVD) in cervical cancer recurrence</title><title>International journal of gynecological cancer</title><addtitle>Int J Gynecol Cancer</addtitle><description>. The purpose of this retrospective study of 118 patients with squamous cell cervical cancer from January 1990 to December 1993 was to evaluate angiogenesis as predictive factor of recurrence in cervical cancer stages II–III treated with standard radiotherapy. Microvessel density (MVD) was evaluated and correlated with other prognostic factors. MVD was greater than 20 in 67.8% of patients with recurrence (P = 0.002) in comparison to 39% of patients without. Disease‐free survival was shorter in stage IIA and MVD &gt;20 (P = 0.0193) as well as for stage IIB (P &lt; 0.05 ), but not for IIIB (P = 0.1613 ). Global survival was significantly shorter when MVD was &gt;20 (P = 0.0316). For stage IIA and MVD &gt;20 survival was shorter (P = 0.0008) for stage IIB (P &lt; 0.05) but not for IIIB (P = 0.14) . Patients younger than 40 years and MVD &gt;20 had poorer disease‐free interval and survival (P = 0.0029). MVD in patients with squamous cell cervical cancer stage II and age younger than 40 may play a role in predicting recurrence and survival.</description><subject>Adult</subject><subject>Age Factors</subject><subject>Aged</subject><subject>angiogenesis</subject><subject>Carcinoma, Squamous Cell - blood supply</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Carcinoma, Squamous Cell - radiotherapy</subject><subject>cervical cancer</subject><subject>Disease-Free Survival</subject><subject>Female</subject><subject>Humans</subject><subject>locally advanced</subject><subject>Microcirculation</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local</subject><subject>Neoplasm Staging</subject><subject>Neovascularization, Pathologic</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Uterine Cervical Neoplasms - blood supply</subject><subject>Uterine Cervical Neoplasms - pathology</subject><subject>Uterine Cervical Neoplasms - radiotherapy</subject><issn>1048-891X</issn><issn>1525-1438</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkF9PHCEUxYmpUWv9CoYn0z7MyN8FXpo0trXbaHyoNn0jLHupbNkZhR11v32Z3Y19LQnhAOfcCz-EMCUtreN80VLJZEMF1y0jhLeUc2Palz109HrxpmoidKMN_XWI3payIIQYRswBOqRioiRn4ghNf8TfXQzRu84D7gNeRp_7J1f8kFzGc-hKXK3x--ufnz_g2GEP-amaE94EMs7gh5yh6ndoP7hU4GS3HqO7r19uL741VzeX04tPV40XSunGsTlRgjISpJPScMeYBG9m0rjgtA6EBKE8E8ZMvHNs5jXXDsRE1zNCw5wfo7Nt3YfcPw5QVnYZi4eUXAf9UKyikhBqVDXqrbF-qJQMwT7kuHR5bSmxI0a7sCMtO9KyI0a7wWhfavR012OYLWH-L7jjVg1ia3ju0wpy-ZOGZ8j2Hlxa3VsykpZKNWNRSuuuqZPqGvu4i8UE6_9-j51-v9xI_hfZv5Aj</recordid><startdate>200311</startdate><enddate>200311</enddate><creator>Cantu De León, D.</creator><creator>Lopez‐Graniel, C.</creator><creator>Frias Mendivil, M.</creator><creator>Chanona Vilchis, G.</creator><creator>Gomez, C.</creator><creator>De La Garza Salazar, J.</creator><general>Blackwell Science Inc</general><general>Blackwell Science Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200311</creationdate><title>Significance of microvascular density (MVD) in cervical cancer recurrence</title><author>Cantu De León, D. ; Lopez‐Graniel, C. ; Frias Mendivil, M. ; Chanona Vilchis, G. ; Gomez, C. ; De La Garza Salazar, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4778-a2d074120f5a5593a225ec9b59afa88f00f47c24996caa2bc838ae468c2401fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Age Factors</topic><topic>Aged</topic><topic>angiogenesis</topic><topic>Carcinoma, Squamous Cell - blood supply</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Carcinoma, Squamous Cell - radiotherapy</topic><topic>cervical cancer</topic><topic>Disease-Free Survival</topic><topic>Female</topic><topic>Humans</topic><topic>locally advanced</topic><topic>Microcirculation</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local</topic><topic>Neoplasm Staging</topic><topic>Neovascularization, Pathologic</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Uterine Cervical Neoplasms - blood supply</topic><topic>Uterine Cervical Neoplasms - pathology</topic><topic>Uterine Cervical Neoplasms - radiotherapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cantu De León, D.</creatorcontrib><creatorcontrib>Lopez‐Graniel, C.</creatorcontrib><creatorcontrib>Frias Mendivil, M.</creatorcontrib><creatorcontrib>Chanona Vilchis, G.</creatorcontrib><creatorcontrib>Gomez, C.</creatorcontrib><creatorcontrib>De La Garza Salazar, J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of gynecological cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cantu De León, D.</au><au>Lopez‐Graniel, C.</au><au>Frias Mendivil, M.</au><au>Chanona Vilchis, G.</au><au>Gomez, C.</au><au>De La Garza Salazar, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Significance of microvascular density (MVD) in cervical cancer recurrence</atitle><jtitle>International journal of gynecological cancer</jtitle><addtitle>Int J Gynecol Cancer</addtitle><date>2003-11</date><risdate>2003</risdate><volume>13</volume><issue>6</issue><spage>856</spage><epage>862</epage><pages>856-862</pages><issn>1048-891X</issn><eissn>1525-1438</eissn><abstract>. The purpose of this retrospective study of 118 patients with squamous cell cervical cancer from January 1990 to December 1993 was to evaluate angiogenesis as predictive factor of recurrence in cervical cancer stages II–III treated with standard radiotherapy. Microvessel density (MVD) was evaluated and correlated with other prognostic factors. MVD was greater than 20 in 67.8% of patients with recurrence (P = 0.002) in comparison to 39% of patients without. Disease‐free survival was shorter in stage IIA and MVD &gt;20 (P = 0.0193) as well as for stage IIB (P &lt; 0.05 ), but not for IIIB (P = 0.1613 ). Global survival was significantly shorter when MVD was &gt;20 (P = 0.0316). For stage IIA and MVD &gt;20 survival was shorter (P = 0.0008) for stage IIB (P &lt; 0.05) but not for IIIB (P = 0.14) . Patients younger than 40 years and MVD &gt;20 had poorer disease‐free interval and survival (P = 0.0029). MVD in patients with squamous cell cervical cancer stage II and age younger than 40 may play a role in predicting recurrence and survival.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Inc</pub><pmid>14675324</pmid><doi>10.1111/j.1525-1438.2003.13399.x</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1048-891X
ispartof International journal of gynecological cancer, 2003-11, Vol.13 (6), p.856-862
issn 1048-891X
1525-1438
language eng
recordid cdi_proquest_miscellaneous_71500197
source MEDLINE; Access via Wiley Online Library
subjects Adult
Age Factors
Aged
angiogenesis
Carcinoma, Squamous Cell - blood supply
Carcinoma, Squamous Cell - pathology
Carcinoma, Squamous Cell - radiotherapy
cervical cancer
Disease-Free Survival
Female
Humans
locally advanced
Microcirculation
Middle Aged
Neoplasm Recurrence, Local
Neoplasm Staging
Neovascularization, Pathologic
Retrospective Studies
Risk Factors
Uterine Cervical Neoplasms - blood supply
Uterine Cervical Neoplasms - pathology
Uterine Cervical Neoplasms - radiotherapy
title Significance of microvascular density (MVD) in cervical cancer recurrence
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T01%3A36%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Significance%20of%20microvascular%20density%20(MVD)%20in%20cervical%20cancer%20recurrence&rft.jtitle=International%20journal%20of%20gynecological%20cancer&rft.au=Cantu%20De%20Le%C3%B3n,%20D.&rft.date=2003-11&rft.volume=13&rft.issue=6&rft.spage=856&rft.epage=862&rft.pages=856-862&rft.issn=1048-891X&rft.eissn=1525-1438&rft_id=info:doi/10.1111/j.1525-1438.2003.13399.x&rft_dat=%3Cproquest_cross%3E71500197%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71500197&rft_id=info:pmid/14675324&rfr_iscdi=true